BIBLIOGRAPHY -...

Chapter – 6

BIBLIOGRAPHY

BibliographyBibliographyBibliographyBibliography

189

BIBLIOGRAPHY

Accardi MV, Daniels BA, Brown PM, Fritschy JM, Tyagarajan SK, Bowie D.

(2014). Mitochondrial reactive oxygen species regulate the strength of inhibitory

GABA-mediated synaptic transmission. Nat Commun, 5:3168.

Adler RA. (2011). Osteoporosis in men: insights for the clinician. Ther Adv

Musculoskelet Dis, 3(4):191–200.

Agata H, Asahina I, Yamazaki Y, Uchida M, Shinohara Y, Honda MJ, Kagami H,

Ueda M. (2007). Effective bone engineering with periosteum-derived cells. J Dent

Res, 86(1):79–83.

Alam K, Ali R. (1999). Human anti-DNA auto antibodies and induced antibodies

against ROS-modified-DNA show similar antigenic binding characteristics. Biochem

Mol Biol Int, 47(5):881-890.

Almeida M, O’Brien CA. (2013). Basic biology of skeletal aging: role of stress

response pathways. J Gerontol A Biol Sci, 68(10):1197-1208.

Amano H, Yamada S, Felix R. (1998). Colony-stimulating factor-1 stimulates the

fusion process in osteoclasts. J Bone Miner Res, 13(5):846-853.

Anderson DM, Maraskovsky E, Billingsley WL, Dougall WC, Tometsko ME, Roux

ER, Teepe MC, DuBose RF, Cosman D, Galibert L. (1997). A homologue of the TNF

receptor and its ligand enhance T-cell growth and dendritic-cell

function. Nature, 390(6656):175–179.

Anderson ME. (1985). Determination of glutathione and glutathione disulfide in

biological samples. Methods Enzymol, 113:548-555.

Ankri S, Miron T, Rabinkov A, Wilchek M, Mirelman D. (1997). Allicin from garlic

strongly inhibits cysteine proteinases and cytopathic effects of Entamoeba histolytica.

Antimicrob Agents Chemother, 41(10):2286–2288.


190

Arif Z, Arjumand S, Ali A, Ali R. (1994). Autoantibodies-like antigen binding

characteristics of induced antibodies against polylysine-polyglutamate complex.

Autoimmunity, 19(1):7-14.

Ascenzi A. (1993). Biomechanics and Galileo Galilei, J Biomech, 26(2):95–100.

Atkins GJ, Kostakis P, Pan B, Farrugia A, Gronthos S, Evdokiou A, Harrison K,

Findlay DM, Zannettino AC. (2003). RANKL expression is related to the

differentiation state of human osteoblasts. J Bone Miner Res, 18(6):1088–1098.

Bab IA, Einhorn TA. (1994). Polypeptide factors regulating osteogenesis and bone

marrow repair. J Cell Biochem, 55(3):358–365.

Backesjo CM, Li Y, Lindgren U, Haldosen LA. (2006). Activation of Sirt1 decreases

adipocyte formation during osteoblast differentiation of mesenchymal stem cells. J

Bone Miner Res, 21(7):993–1002.

Backesjo CM, Li Y, Lindgren U, Haldosen LA. (2009). Activation of Sirt1 decreases

adipocyte formation during osteoblast differentiation of mesenchymal stem cells.

Cells Tissues Organs, 189(1-4):93–97.

Balentine DA, Harbowy ME, Graham HN. (1998). in: G.A. Spiller (Ed.), Caffeine,

CRC Press, Boca Raton, NY, 1998, pp. 35–72.

Bass E, French DD, Bradham DD, Rubenstein LZ. (2007). Risk-adjusted mortality

rates of elderly veterans with hip fractures. Ann Epidemiol, 17(7):514–519.

Bateman TA, Countryman S. (2002). Osteoprotegerin and bone loss associated with

spaceflight. Drug Discov Today, 7(8):456–457.

Bax BE, Alam AS, Banerji B, Bax CM, Bevis PJ, Stevens CR, Moonga BS, Blake

DR, Zaidi M. (1992). Stimulation of osteoclastic bone resorption by hydrogen

peroxide. Biochem Biophys Res Commun, 183(3):1153–1158.

Bhabak KP, Mugesh G. (2010). Functional mimics of glutathione peroxidase:

bioinspired synthetic antioxidants. Acc Chem Res, 43(11):1408–1419.


191

Bharti AC, Takada Y, Aggarwal BB. (2004). Curcumin (diferuloylmethane) inhibits

receptor activator of NF-κB ligand-induced NF-κB activation in osteoclast precursors

and suppresses osteoclastogenesis. J Immunol, 172(10):5940–5947.

Block E. (1985). The chemistry of garlic and onions. Sci Am, 252(3):114–119.

Block E. (2010). Garlic and other alliums: the lore and the science. Cambridge: Royal

Society of Chemistry.

Block K, Gorin Y. (2012). Aiding and abetting roles of NOX oxidases in cellular

transformation. Nat Rev Cancer, 12(9):627–637.

Boissy P, Andersen TL, Abdallah BM, Kassem M, Plesner T, Jean-Marie Delaisse

JM. (2005). Resveratrol inhibits myeloma cell growth, prevents osteoclast formation,

and promotes osteoblast differentiation. Cancer Res, 65(21):9943-9952.

Boskey AL, Gadaleta S, Gundberg C, Doty SB, Ducy P, Karsenty G. (1998). Fourier

transform infrared micro spectroscopic analysis of bones of osteocalcin-deficient mice

provides insight into the function of osteocalcin. Bone, 23(3):187–196.

Boskey AL, Marks SC, Jr. (1985). Mineral and matrix alterations in the bones of

incisors-absent (ia/ia) osteopetrotic rats. Calcif Tissue Int, 37(3):287–292.

Boyce BF, Xing L. (2007). Biology of RANK, RANKL and osteoprotegerin. Arthritis

Res Ther, 9 Suppl 1:S1.

Boyce BF, Xing L. (2008). Functions of RANKL/RANK/OPG in bone modeling and

remodeling. Arch Biochem Biophys, 473(2):139–146.

Boyle WJ, Simonet WS, Lacey DL. (2003). Osteoclast differentiation and activation.

Nature, 423(6937):337-342.

Bradford MM. (1976). A rapid and sensitive method for the quantitation of

microgram quantities of protein utilizing the principle of protein-dye binding. Anal

Biochem, 72:248-254.


192

Brodnitz MH, Pascale JV, Derslice LV. (1971). Flavor components of garlic extract.

J Agric Food Chem, 19:273–275.

Brooker RJ. (2011). Genetics: analysis and principles (4th ed.). McGraw-Hill

Science.

Brown K, Gerstberger S, Carlson L, Franzoso G, Siebenlist U. (1995). Control of

IκB alpha proteolysis by site-specific, signal induced phosphorylation. Science,

267(5203):1485–1488.

Bruzzaniti A, Baron R. (2006). Molecular regulation of osteoclast activity. Rev

Endocr Metab Disord, 7(1-2):123–139.

Bryk R, Lima CD, Erdjument-Bromage H, Tempst P, Nathan C. (2002). Metabolic

enzymes of mycobacteria linked to antioxidant defense by a thioredoxin-like protein.

Science, 295(5557):1073–1077.

Buckley KA, Chan BYY, Fraser WD, Gallagher JA. (2005). Human osteoclast

culture from peripheral blood monocytes: phenotypic characterization and

quantitation of resorption. Methods Mol Med, 107:55–68.

Burge R, Dawson-Hughes B, Solomon DH, Wong JB, King A, Tosteson A. (2007).

Incidence and economic burden of osteoporosis-related fractures in the United States,

2005–2025. J Bone Miner Res, 22(3):465–475.

Burr DB, Robling AG, Turner CH. (2002). Effects of biomechanical stress on bones

in animals. Bone, 30(5):781–786.

Byun MR, Sung MK, Kim AR, Lee CH, Jang EJ, Jeong MG, Noh M, Hwang ES,

Hong JH. (2014). (-)-Epicatechingallate (ECG) stimulates osteoblast differentiation

via runt-related transcription factor 2 (Runx2) and transcriptional coactivator with

PDZ-binding motif (TAZ)-mediated transcriptional activation. J Biol Chem,

289(14):9926-9935.

Cao X. (2011). Targeting osteoclast-osteoblast communication. Nat Med, 17(11):

1344–1346.


193

Cao Y, Zhou Z, Crombrugghe BD, Nakashima K, Guan H, Duan X, Jia SF,

Kleinerman ES. (2005). Osterix, a transcription factor for osteoblast differentiation,

mediates antitumor activity in murine osteosarcoma. Cancer Res, 65(4):1124-1128.

Cardullo RA, Agrawal S, Flores C, Zamecnik PC, Wolf DE. (1988). Detection of

nucleic acid hybridization by nonradiative fluorescence resonance energy transfer.

Proc Natl Acad Sci U S A., 85(23):8790-8794.

Casarin RC, Casati MZ, Pimentel SP, Cirano FR, Algayer M, Pires PR, Ghiraldini B,

Duarte PM, Ribeiro FV. (2014). Resveratrol improves bone repair by modulation of

bone morphogenetic proteins and osteopontin gene expression in rats. Int J Oral

Maxillofac Surg, 43(7):900–906.

Castaño-Betancourt M C, Rivadeneira F, Bierma-Zeinstra S, Kerkhof HJM, Hofman

A, Uitterlinden AG, van Meurs JBC. (2013). Bone parameters across different types

of hip osteoarthritis and their relationship to osteoporotic fracture risk. Arthritis

Rheum, 65(3):693-700.

Chen D, Milacic V, Chen MS, Wan SB, Lam WH, Huo C, Landis-Piwowar KR, Cui

QC, Wali A, Chan TH, Dou QP. (2008). Tea polyphenols, their biological effects and

potential molecular targets. Histol Histopathol, 23(4):487-496.

Chen HL, Deng LL, Li JF. (2013). Prevalence of osteoporosis and its associated

factors among older men with type 2 diabetes. Int J Endocrinol, 2013:285729.

Chen J, McKee MD, Nanci A, Sodek J. (1994). Bone sialoprotein mRNA expression

and ultrastructural localization in fetal porcine calvarial bone: comparisons with

osteopontin. Histochem J, 26(1):67–78.

Chen L, Holmstrom K, Qiu W, Ditzel N, Shi K, Hokland L, Kassem M. (2014).

MicroRNA-34a Inhibits Osteoblast Differentiation and In Vivo Bone Formation of

Human Stromal Stem Cells. Stem Cells, 32(4):902-912.

Clarke B. (2008). Normal bone anatomy and physiology.Clin J Am Soc Nephrol, 3

Suppl 3:S131-S139.


194

Clover J, Dodds RA, Gowen G. (1992). Integrin subunit expression by human

osteoblasts and osteoclasts in situ and in culture. J Cell Sci, 103(Pt 1): 267-271.

Corpas FJ, Barroso JB, del Río LA. (2001).Peroxisomes as a source of reactive

oxygen species and nitric oxide signal molecules in plant cells. Trends Plant

Sci, 6(4):145–150.

Corpas FJ, Fernández-Ocana A, Carreras A, Valderrama R, Luque F, Esteban FJ,

Rodríguez-Serrano M, Chaki M, Pedrajas JR, Sandalio LM, del Río LA, Barroso JB.

(2006). The expression of different superoxide dismutase forms is cell-type dependent

in olive (Oleaeuropaea L.) leaves. Plant Cell Physiol, 47(7):984–994.

Cremlyn RJW. (1996). An introduction to organosulfur chemistry. Chichester:Wiley.

Crespy V and Williamson G. (2004). A review of the health effects of green tea

catechins in in vivo animal models. J Nutr, 134(12 Suppl):3431S-3440S.

Cummings SR, San Martin J, McClung MR, Siris ES, Eastell R, Reid IR, Delmas P,

Zoog HB, Austin M, Wang A, Kutilek S, Adami S, Zanchetta J, Libanati C, Siddhanti

S, Christiansen C, FREEDOM Trial. (2009). Denosumab for prevention of fractures

in postmenopausal women with osteoporosis. N Engl J Med, 361(8):756–765.

D’ippolito G, Schiller PC, Ricordi C, Roos BA, Howard GA. (1999). Age-related

osteogenic potential of mesenchymal stromal stem cells from human vertebral bone

marrow. J Bone Miner Res, 14(7):1115–1122.

Dallas SL, Prideaux M, Bonewald LF. (2013). The osteocyte: an endocrine cell . . .

and more. Endocr Rev, 34(5):658–690.

Darnay BG, Haridas V, Ni J, Moore PA, Aggarwal BB.(1998). Characterization of

the intracellular domain of receptor activator of NF-kappaB (RANK).Interaction with

tumor necrosis factor receptor-associated factors and activation of NF-kappa B and c-

Jun N-terminal kinase. J Biol Chem, 273(32):20551–20555.

Darnay BG, Ni J, Moore PA, Aggarwal BB. (1999). Activation of NF-kappa B by

RANK requires tumor necrosis factor receptor-associated factor (TRAF) 6 and NF-


195

kappaB-inducing kinase. Identification of a novel TRAF6 interaction motif. J Biol

Chem, 274(12):7724–7731.

Devasagayam TPA, Tilak JC, Boloor KK, Sane KS, Ghaskadbi SS, Lele RD. (2004).

Free radicals and antioxidants in human health: current status and future prospects. J

Assoc Physicians India, 52:794-804.

Dorai T, Diouri J, O’Shea O, Doty SB. (2014). Curcumin inhibits prostate cancer

bone metastasis by up-regulating bone morphogenic protein-7 in vivo. J Cancer Ther,

15(4):369-386.

Dougall WC, Holen I, González Suárez E. (2014). Targeting RANKL in metastasis.

Bonekey Rep, 3:519.

Dubois EA, Rissmann R, Cohen AF. (2011). Denosumab. Br J Clin Pharmacol,

71(6):804-806.

Duncan RL, Akanbi KA, Farach-Carson MC. (1998). Calcium signals and calcium

channels in osteoblastic cells. Semin Nephrol, 18(2):178-190.

Ebeling PR. (2008). Clinical practice. Osteoporosis in men. N Engl J Med,

358(14):1474–1430.

Ehrlich PJ, Lanyon LE. (2002). Mechanical strain and bone cell function: a

review. Osteoporos Int, 13(9):688–700.

Einhorn TA, Boskey AL, Gundberg CM, Vigorita VJ, Devlin VJ and Beyer MM.

(1988).The mineral and mechanical properties of bone in chronic experimental

diabetes. J Orthop Res, 6(3):317–323.

Einhorn TA. (1994). Bone metabolism and metabolic bone disease. In orthopaedic

knowledge update 4 home study syllabus (J. W. Frymoyer, ed.). Am Acad Orthop

Surg, Rosemont, 69–88.

Fatima Z, Hameed S, Islam N. (2012). Epigallocatechin-3-gallate (EGCG), a green

tea polyphenol suppresses bacilli-induced augmented expression of M. tuberculosis

85B proinflammatory TNF-α in human monocytes. Int J Sci Res Pub, 2(2):1-6.


196

Fattore AD, Teti A, Rucci N. (2008). Osteoclast receptors and signaling. Arch

Biochem Biophys, 473(2):147–160.

Faust J, Lacey DL, Hunt P, Burgess TL, Scully S, Van G, Eli A, Qian YX, Shalhoub

V. (1999). Osteoclast markers accumulate on cells developing from human peripheral

blood mononuclear precursors. J Cell Biochem, 72(1):67-80.

Fernández-Real JM, Ricart W. (2011). Osteocalcin: a new link between bone and

energy metabolism. Some evolutionary clues. Curr Opin Clin Nutr Metab Care,

14(4):360-366.

Ferrari N, McDonald L, Morris JS, Cameron ER, Blyth K. (2013). RUNX2 in

mammary gland development and breast cancer. J Cell Physiol, 228(6):1137–1142.

Finkel T, Holbrook NJ. (2000). Oxidants, oxidative stress and the biology of ageing.

Nature, 408(6809):239–247.

Forwood MR, Turner CH. (1995). Skeletal adaptations to mechanical usage: results

from tibial loading studies in rats. Bone, 17(4 Suppl):197S–205S.

Franz-Odendaal TA, Hall BK, Witten PE. (2006). Buried alive: how osteoblasts

become osteocytes. Dev Dyn, 235(1):176–190.

Fraser LA, Vogt KN, Adachi JD, Thabane L. (2011). Fracture risk associated with

continuation versus discontinuation of bisphosphonates after 5 years of therapy in

patients with primary osteoporosis: a systematic review and meta-analysis. Ther Clin

Risk Manag, 7:157–166.

Fratzl P, Schreiber S, Roschger P, Lafage MH, Rodan G, Klaushofer K. (1996).

Effects of sodium fluoride and alendronate on the bone mineral in minipigs: a small-

angle x-ray scattering and backscattered electron imaging study. J Bone Miner Res,

11(2):248–253.

Frost HM, Thomas CC. (1964). Bone remodeling dynamics. Arthritis Rheum,

7(5):545.


197

Fujikawa Y, Quinn JM, Sabokbar A, McGee JO, Athanasou NA. (1996). The human

osteoclast precursor circulates in the monocyte fraction. Endocrinology, 137(9):4058-

4060.

Fukunaga T, Zou W, Warren JT, Teitelbaum SL. (2014). Vinculin regulates

osteoclast function. J Biol Chem, 289(19):13554-13564.

Galibert L, Tometsko ME, Anderson DM, Cosman D, Dougall WC. (1998). The

involvement of multiple tumor necrosis factor receptor (TNFR)-associated factors in

the signaling mechanisms of receptor activator of NF-kappa B, a member of the

TNFR super family. J Biol Chem, 273(51):34120–34127.

Garrett IR, Boyce BF, Oreffo RO, Bonewald L, Poser J, Mundy GR. (1990).

Oxygen-derived free radicals stimulate osteoclastic bone resorption in rodent bone in

vitro and in vivo. J Clin Invest, 85(3):632-639.

Goel V, Kar P. (2010). Hepatic osteodystrophy.Trop Gastroenterol, 31(2):82-86.

Goldring SR, Goldring MB. (2007).Eating bone or adding it: the wnt pathway

decides. Nat Med, 13(2):133–134.

Gong JK, Arnold JS, Cohn SH. (1964). Composition of trabecular and cortical

bone.Anat Rec, 149:325–332.

Graham HN. (1992). Green tea composition, consumption and polyphenol

chemistry. Prev Med, 21(3):334–350.

Guglielmi G, Scalzo G. (2010). Imaging tools transform diagnosis of

osteoporosis. Diagnostic Imaging Europe, 26:7–11.

Ha H, Kwak HB, Lee SW, Jin HM, Kim HM, Kim HH, Lee ZH. (2004). Reactive

oxygen species mediate RANK signaling in osteoclasts. Exp Cell Res, 301(2):119–

127.

Ha H, Shim KS, An H, Kim T, Ma JY. (2013). Water extract of Spatholobus

suberectus inhibits osteoclast differentiation and bone resorption. BMC Complement

Altern Med, 13:112.


198

Habold C, Momken I, Ouadi A, Bekaert V, Brasse D. (2011).Effect of prior treatment

with resveratrol on density and structure of rat long bones under tail-suspension. J

Bone Miner Metab, 29(1):15–22.

Hall SJ. (2007). Basic Biomechanics. 5th edition. New York, NY: McGraw-Hill, pp

88.

Handy DE, Loscalzo J. (2012).Redox regulation of mitochondrial function.Antioxid

Redox Signal, 16(11):1323–1367.

Hartel C, Bein G, Kirchner H, Kluter H. A human whole-blood assay for analysis of

T-cell function by quantification of cytokine mRNA. Scand J Immunol, 49(6):649–

654.

Hasan N, Siddiqui MU, Toossi Z, Khan S, Iqbal J, Islam N. (2007). Allicin induced

suppression of Mycobacterium tuberculosis 85B mRNA in human monocytes.

Biochem Biophys Res Comm, 355(2):471-476.

Hasan N, Yusuf N, Toossi Z, Islam N. (2006). Suppression of Mycobacterium

tuberculosis induced reactive oxygen species (ROS) and TNF-alpha expression in

human monocytes by allicin. FEBS Lett, 580(10):2517-2522.

He X, Andersson G, Lindgren U, Li Y. (2010). Resveratrol prevents RANKL-induced

osteoclast differentiation of murine osteoclast progenitor RAW 264.7 cells through

inhibition of ROS production. Biochem Biophys Res Commun, 401(3):356–362.

Hegarty VM, May HM, Khaw KT. (2000). Tea drinking and bone mineral density in

older women.Am J ClinNutr, 71(4):1003-1007.

Heinemann C, Heinemann S, Worch H, Hanke T. (2011). Development of an

osteoblast/osteoclast coculture derived by human stromal cells and human monocytes

for biomaterials testing. Eur Cell Mater, 21:80-93.

Heinemann DF. (2000). Osteoporosis: an overview of the National Osteoporosis

Foundation clinical practice guide. Geriatrics, 55(5):31–36.


199

Herrmann M, Umanskaya N, Wildemann B, Colaianni G, Widmann T, Zallone A,

Hermann W. (2008). Stimulation of osteoblast activity by homocysteine.J Cell Mol

Med, 12(4):1205-1210.

Higdon JV, Frei B. (2003). Tea catechins and polyphenols: health effects,

metabolism, and antioxidant functions. Crit Rev Food Sci Nutr, 43(1):89–143.

Holland PM, Abransom RD, Watson RD, Gelfand DH. (1991). Detection of specific

polymerase chain reaction product by utilizing 5/ to 3/ exonuclease activity of

Thermus aquaticus DNA polymerase.Proc Natl Acad Sci, 88(16):7276-7280.

Horowitz M, Jilka RL. (1992). Colony stimulating factors in bone remodeling. In

cytokines and bone metabolism (M. Gowen, ed.). CRC Press, Boca Raton, FL, 185–

227.

Howitz KT, Bitterman KJ, Cohen HY, Lamming DW, Lavu S, Jason G. Wood JG,

Zipkin RE, Chung P, Kisielewski A, Zhang LL, Scherer B, Sinclair DA. (2003).

Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan.

Nature, 425(6954):191–196.

Hsieh YF, Turner CH. (2001). Effects of loading frequency on mechanically induced

bone formation. J Bone Miner Res, 16(5):918–924.

Hui M, Hu M, Tenenbaum HC. (1993). Changes in cell adhesion and cell

proliferation are associated with expression of tissue non-specific alkaline

phosphatase. Cell Tissue Res, 274(3):429–437.

Ikeda F, Nishimura R, Matsubara T, Tanaka S, Inoue J, Reddy SV, Hata K,

Yamashita K, Hiraga T, Watanabe T, Kukita T, Yoshioka K, Rao A, Yoneda T.

(2004). Critical roles of c-Jun signaling in regulation of NFAT family and RANKL-

regulated osteoclast differentiation. J Clin Invest, 114(4):475-484.

Islam N, Ali R. (1998). Immunological studies on DNA Lysine Photo adduct.

Biochem Mol Bio Int, 45(3):453-464.


200

Islam N, Kanost RA, Teixeira L, Johnson J, Hejal R, Aung H, Wilkinson RJ, Hirsch

CS, Toossi Z. (2004). The role of cellular activation and tumor necrosis factor (TNF-

alpha) in the early expression of M. Tuberculosis 85B mRNA in human alveolar

macrophages. J Infect Dis, 190(2):341-351.

Islam S, Islam N, Kermode T, Johnstone B, Moskowitz RW, Goldberg VM,

Mukhtar H, Melamud CJ, Haqqi TM. (2000). Activation of Caspase-3 in human

chondrosarcoma cells by tumor necrosis factor-α and epigallocatechin-3-gallate in

vitro. Res Comm, 270(3):793-797.

Jiang HX, Majumdar SR, Dick DA, Moreau M, Raso J, Otto DD, Johnson DW.

(2005). Development and initial validation of a risk score for predicting in-hospital

and 1-year mortality in patients with hip fractures. J Bone Miner Res, 20(3):494–500.

Jilka RL. (2003). Biology of the basic multicellular unit and the pathophysiology of

osteoporosis. Med Pediatr Oncol, 41(3):182–185.

Jimi E, Nakamura I, Amano H, Taguchi Y, Tsurukai T, Tamura M, Takahashi N,

Suda T. (1996). Osteoclast function is activated by osteoblastic cells through a

mechanism involving cell-to-cell contact. Endocrinology, 137(8):2187-2190.

Jin P, Wu H, Xu G, Zheng L, Zhao J. (2014). Epigallocatechin-3-gallate (EGCG) as a

pro-osteogenic agent to enhance osteogenic differentiation of mesenchymal stem cells

from human bone marrow: an in vitro study. Cell Tissue Res, 356(2):381-390.

Junko M, Giichi T, Hiroyuki A, Hiroaki S, Jun NT, Kunihiro M, Naoki S.

(2002). Receptor activator of TNF-kappa B ligand (RANKL) activates TAK1

mitogen-activated protein kinase kinase kinase through a signaling complex

containing RANK, TAB2 and TRAF6. Mol Cell Biol, 22(4):992–1000.

Kaeberlein M, McVey M, Guarente L. (1999). The SIR2/3/4 complex and SIR2

alone promote longevity in Saccharomyces cerevisiae by two different mechanisms.

Genes Dev, 13(19):2570–2580.


201

Kamon M, Zhao R, Sakamoto K. (2010). Green tea polyphenol (−)-epigallocatechin

gallate suppressed the differentiation of murine osteoblastic MC3T3-E1 cells. Cell

Biol Int, 34(1):109–116.

Kang SN, Lee JS, Park JH, Cho JH, Park JH, Cho KK, Lee OH, Kim IS. (2014). In

vitro anti-osteoporosis properties of diverse Korean Drynariae rhizoma phenolic

extracts. Nutrients, 6(4):1737-1751.

Kanis JA. (2002). Diagnosis of osteoporosis and assessment of fracture risk.Lancet,

359(9321):1929–1936.

Kanzaki H, Shinohara F, Kajiya M, Kodama T. (2014).

The Keap1/Nrf2 protein axis plays a role in osteoclast differentiation by regulating int

racellular reactive oxygen species signaling. J Biol Chem, 288(32):23009-23020.

Kaplan FS, Hayes WC, Keaveny TM, Boskey AL, Einhorn TA, Iannotti JP. (1994).

Form and function of bone, in orthopaedic basic science (S. R. Simon, ed.). Am Acad

Orthop Surg, 127–184.

Katagiri T, Takahashi N. (2002). Regulatory mechanisms of osteoblast and osteoclast

differentiation. Oral Dis, 8(3):147-159.

Kaur J, Kukreja S, Kaur A, Malhotra N, Kaur R. (2012). The oxidative stress in

cataract patients. J Clin Diagn Res, 6(10):1629-1632.

Kawai K, Tsuno NH, Kitayama J, Okaji Y, Yazawa K, Asakagi M, Sasaki S,

Watanabe T, Takahashi K, Nagawa H. (2005). Epigallocatechin gallate induces

apoptosis of monocytes. J Allergy Clin Immonol, 11591):186-191.

Ke K, Sul OJ, Choi EK, Safdar AM, Kim ES, Choi HS. (2014). Reactive oxygen

species induce the association of SHP-1 with c-Src and the oxidation of both to

enhance osteoclast survival. Am J Physiol Endocrinol Metab, 307(1):E61-E70.

Kerschnitzki M, Kollmannsberger P, Burghammer M, Duda G N, Weinkamer R,

Wagermaier W, Fratzl P. (2013). Architecture of the osteocyte network correlates

with bone material quality. J Bone Miner Res, 28(8):1837–1845.


202

Khan N, Afaq F, Saleem M, Ahmad N, Mukhtar H. (2006). Targeting multiple

signaling pathways by green tea polyphenol (-)-epigallocatechin-3-gallate. Cancer

Res, 66(5):2500-2505.

Khosla S, Lufkin EG, Hodgson SF, Fitzpatrick LA, Melton LJ 3rd. (1994).

Epidemiology and clinical features of osteoporosis in young individuals. Bone,

15(5):551–555.

Khosla S. (2001). Minireview: the OPG/RANKL/RANK system. Endocrinology,

142912):5050-5055.

Kim DH, Vaccaro AR. (2006). Osteoporotic compression fractures of the spine;

current options and considerations for treatment. Spine J, 6(5):479–487.

Kim H, Kim T, Jeong B-C, Cho I-T, Han D, Takegahara N, Negishi-Koga T,

Takayanagi H, Lee JH, Sul J-Y, Prasad V, Lee SH, Choi Y. (2013). Tmem64

modulates calcium signaling during RANKL-mediated osteoclast differentiation. Cell

Metab, 17(2):249–260.

Kim HH, Lee DE, Shin JN, Lee YS, Jeon YM, Chung CH, Ni J, Kwon BS, Lee ZH.

(1999). Receptor activator of NF-kappa B recruits multiple TRAF family adaptors and

activates c-Jun N-terminal kinase. FEBS Lett, 443(3):297–302.

Kim JL, Kim YH, Kang MK, Gong JH, Han SJ, Kang YH. (2013). Antiosteoclastic

activity of milk thistle extract after ovariectomy to suppress estrogen deficiency-

induced osteoporosis.Biomed Res Int, 2013:919374.

Kobayashi T, Kronenberg H. (2005). Minireview: transcriptional regulation in

development of bone. Endocrinology, 14693):1012–1017.

Koh JM, Lee YS, Kim YS, Kim DJ, Kim HH, Park JY, Lee KU, Kim GS. (2006).

Homocysteine enhances bone resorption by stimulation of osteoclast formation and

activity through increased intracellular ROS generation. J Bone Miner Res,

21(7):1003–1011.


203

Kolev TM, Velcheva EA, Stamboliyska BA, Spiteller M. (2005). DFT and

experimental studies of the structure and vibrational spectra of curcumin. Int J

Quantum Chem, 102:1069–1079.

Komori T. (2005). Regulation of skeletal development by the runx family of

transcription factors. J Cell Biochem, 95(3):445-53.

Kong YY, Feige U, Sarosi I, Bolon B, Tafuri A, Morony S, Capparelli C, Li J, Elliott

R, McCabe S, Wong T, Campagnuolo G, Moran E, Bogoch ER, Van G, Nguyen LT,

Ohashi PS, Lacey DL, Fish E, Boyle WJ, Penninger JM. (1999). Activated T cells

regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin

ligand. Nature, 402(6759):304–309.

Krakauer T. (2008). Nuclear factor-kappa B: fine-tuning a central integrator of

diverse biologic stimuli. Int Rev Immunol, 2795):286–292.

Kupisiewicz K, Boissy P, Abdallah BM, Hansen FD, Erben RG, Savouret JF, Soe K,

Andersen TL, Plesner T, Delaisse JM. (2010). Potential of resveratrol analogues as

antagonists of osteoclasts and promoters of osteoblasts.Calcif Tissue Int, 87(5):437-

449.

Lacey DL, Boyle WJ, Simonet WS, Kostenuik PJ, Dougall WC, Sullivan JK, San

Martin J, Dansey R. (2012). Bench to bedside: elucidation of the OPG-RANK-

RANKL pathway and the development of denosumab. Nat Rev Drug Discov,

11(5):401-419.

Lacey DL, Timms E, Tan HL, Kelley MJ, Dunstan CR, Burgess TL, Elliott R,

Colombero A, Elliott G, Scully S, Hsu H, Sullivan J, Hawkins H, Davy E, Capparelli

C, Eli A, Qian YX, Kaufman S, Sarosi I, Shalhoub V, Senaldi G, Guo J, Boyle J,

Boyle WJ. (1998). Osteoprotegerin ligand is a cytokine that regulates osteoclast

differentiation and activation. Cell, 93(2):165–176.

Laemmli UK. (1970). Cleavage of structural proteins during the assembly of the head

of bacteriophage T4. Nature, 227(5259):680-685.


204

Lambert JD, Yang CS. (2003). Mechanisms of cancer prevention by tea

constituents.J Nutr, 133910):3262S–3267S.

Lampropoulos CE, Papaioannou I, D’Cruz DP. (2012). Osteoporosis-- a risk factor

for cardiovascular disease? Nat Rev Rheumatol, 8(10):587-598.

Lang A, Lahav M, Sakhnini E, Barshack I, Fidder HH, Avidan B, Bardan E,

Hershkoviz R, Bar-Meir S, Chowers Y. (2004). Allicin inhibits spontaneous and

TNF-α induced secretion of proinflammatory cytokines and chemokines from

intestinal epithelial cells. Clin Nutr, 23(5):1199–1208.

Lee NK, Choi YG, Baik JY, Han SY, Jeong DW, Bae YS, Kim N, Lee SY. (2005). A

crucial role for reactive oxygen species in RANKL-induced osteoclast differentiation.

Blood, 106(3):852–859.

Lee TJ, Jang J, Kang S, Jin M, Shin H, Kim DW, Kim BS. (2013). Enhancement of

osteogenic and chondrogenic differentiation of human embryonic stem cells by

mesodermal lineage induction with BMP-4 and FGF2 treatment. Biochem Biophys

Res Commun, 430(2):793–797.

Li Q, Verma IM. (2002). NF-kappa B regulation in the immune system. Nat Rev

Immunol, 2(10):725–734.

Li X, Fang P, Mai J, Choi ET, Wang H, Yang XF. (2013). Targeting mitochondrial

reactive oxygen species as novel therapy for inflammatory diseases and cancers. J

Hematol Oncol, 6:19.

Li Y, Danmark S, Edlund U, Finne-Wistrand A, He X, Norgard M, Blomen E,

Hultenby K, Andersson G, Lindgren U. (2011). Resveratrol-conjugated poly-e-

caprolactone facilitates in vitro mineralization and in vivo bone regeneration. Acta

Biomater, 7(2):751-758.

Li Y, Huang TT, Carlson EJ, Melov S, Ursell PC, Olson JL, Noble LJ, Yoshimura

MP, Berger C, Chan PH, Wallace DC, Epstein CJ. (1995). Dilated cardiomyopathy

and neonatal lethality in mutant mice lacking manganese superoxide dismutase. Nat

Genet, 11(4):376–381.


205

Lin SC, Kao SY, Kang NT, Liu WC. (2013). Resveratrol inhibition

osteoclastogenesis induced by RANKL through decrease preosteoclast formation.

Adv Mater Res, 647:124-128.

Lin YZ, Yao SY, Veach RA, Torgerson TR, Hawiger J. (1995). Inhibition of nuclear

translocation of transcription factor NF-kappa B by a synthetic peptide containing a

cell membrane-permeable motif and nuclear localization sequence. J Biol Chem,

270(24):14255–14258.

Liu ZP, Li WX, Yu B, Huang J, Sun J, Huo JS, Liu CX. (2005). Effects of trans-

resveratrol from Polygonum cuspidatum on bone loss using the ovariectomized rat

model. J Med Food, 8(1):14–19.

Lorenz M, Urban J, Engelhardt U, Baumann G, Stang K, Stang V. (2009). Green and

black teas are equally potent stimuli of NO production and vasodilation: new insights

into tea ingredients involved. Basic Res Cardiol, 104(1):100-110.

Lotito SB, Frei B. (2006). Consumption of flavonoid-rich foods and increased plasma

antioxidant capacity in humans: Cause, consequence, or epiphenomenon? Free Rad

Biol Med, 41(12):1727–1746.

Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. (1951). Protein measurement with

the Folin phenol reagent. J Biol Chem, 193(1):265-275.

Madamanchi NR, Runge MS. (2007). Mitochondrial dysfunction in

atherosclerosis.Circ Res, 100(4):460–473.

Mah YJ, Song JS, Kim SO, Lee JH, Jeon M, Jung UW, Moon SJ, Kim JH, Choi HJ.

(2014). The effect of epigallocatechin-3-gallate (EGCG) on human alveolar bone cells

both in vitro and in vivo. Arch Oral Biol, 59(5):539-549.

Martin TJ, Sims NA. (2005). Osteoclast-derived activity in the coupling of bone

formation to resorption.Trends Mol Med, 11(2):76–81.

Mates JM, Perez-Gomez C and De Castro IN. (1999). Antioxidant enzymes and

human diseases. Clin Biochem, 32(8):595–603.


206

McConnell D. (1962). The crystal structure of bone. Clin Orthop, 23:253–268.

McKay DL, Blumberg JB. (2007). Roles for epigallocatechin gallate in

cardiovascular disease and obesity: an introduction. J Am College Nutr, 26:362S-

365S.

Melchior F, Kindl H. (1990). Grapevine stilbene synthase cDNA only slightly

differing from chalcone synthese cDNA is expressed in Escherichia Coli into a

catalytically active enzyme. FEBS Lett, 268(1):17-20.

Merril CR, Goldman D, Van Keuren ML. (1983). Silver staining methods for

polyacrylamide gel electrophoresis. Methods Enzymol, 96:230-239.

Mesiter A, Anderson ME. (1983). Glutathione. Annu Rev Biochem, 52:711–760.

Meyer MB, Benkusky NA, Pike JW. (2014). The RUNX2 cistrome in osteoblasts:

characterization, down regulation following differentiation and relationship to gene

expression. J Biol Chem, 289(23):16016-16031.

Mohandas J, Marshall JJ, Duggin GG, Horvath JS, Tiller DJ. (1984). Differential

distribution of glutathione and glutathione-related enzymes in rabbit kidney. Possible

implications in analgesic nephropathy. Biochem Pharmacol, 33(11):1801-1807.

Momken I, Stevens L, Bergouignan A, Desplanches D, Rudwill F, Chery I, Zahariev

A, Zahn S,Stein TP,Sebedio JL,Pujos-Guillot E,Falempin M,Simon C,Coxam V,

Andrianjafiniony T,Gauquelin-Koch G,Picquet F,Blanc S. (2011). Resveratrol

prevents the wasting disorders of mechanical unloading by acting as a physical

exercise mimetic in the rat. FASEB J, 25(10):3646–3660.

Moon HJ, Ko WK, Han SW, Kim DS, Hwang YS, Park HK, Kwon IK. (2012).

Antioxidants, like coenzyme Q10, selenite, and curcumin, inhibited osteoclast

differentiation by suppressing reactive oxygen species generation. Biochem Biophys

Res Commun, 418(2):247–253.


207

Morgan AM, Lee HW, Lee SH, Lim CH, Jang HD, Kim YH. (2014). Anti-

osteoporotic and antioxidant activities of chemical constituents of the aerial parts of

Ducrosia ismaelis. Bioorg Med Chem Lett, pii:S0960-894X(14)00586-1.

Morgan EF, Barnes GL, Einhorn. (2008). The bone organ system: form and function,

in Osteoporosis, Marcus R, Feldman D, Nelson DA, Rosen CJ, Eds., Academic, San

Diego, Calif, USA, 3rd edition, Chapter 1, pp.1-25.

Morinobu A, Biao W, Tanaka S, Horiuchi M, Jun L, Tsuji G, Sakai Y, Kurosaka M,

Kumagai S. (2008). (–)-Epigallocatechin-3-Gallate suppresses osteoclast

differentiation and ameliorates experimental arthritis in mice. Arthritis Rheum,

5897):2012–2018.

Mukhtar H, Ahmad N. (2000). Tea polyphenols: prevention of cancer and optimizing

health. Am J Clin Nutr, 71(6 Suppl):1698S–1702S, discussion 1703S–1704S.

Muller FL, Lustgarten MS, Jang Y, Richardson A, Van Remmen H (2007).Trends in

oxidative aging theories. Free Radic Biol Med, 43(4);477–503.

Nagal DG, Ferreira D, Zhou YD. (2006). Epigallocatechin-3-gallate (EGCG):

chemical and biomedical perspectives. Photochemistry, 67(17):1849-1855.

Nakagawa H, Wachi M, Woo JT, Kato M, Kasai S, Takahashi F, Lee IS, Nagai K.

(2002). Fenton reaction is primarily involved in a mechanism of (-)-epigallocatechin-

3-gallate to induce osteoclastic cell death. Biochem Biophys Res Commun,

292(1):94-101.

Nakagawa N, Kinosaki M, Yamaguchi K, Shima N, Yasuda H, Yano K, Morinaga T,

Higashio K. (1998). RANK is the essential signaling receptor for osteoclast

differentiation factor in osteoclastogenesis, Biochem Biophys Res Commun,

253(2):395– 400.

Nakashima K, Zhou X, Kunkel G, Zhang Z, Deng JM, Behringer RR, de

Crombrugghe B. (2002). The novel zinc finger-containing transcription factor osterix

is required for osteoblast differentiation and bone formation. Cell, 108(1):17-29.


208

Nazrun AS, Norazlina M, Norliza M, Nirwana SI. (2012). The Anti-Inflammatory

Role of Vitamin E in Prevention of Osteoporosis. Adv Pharmacol Sci, 2012:142702.

Negishi-Koga T, Shinohara M, Komatsu N, Bito H, Kodama T, Friedel RH,

Takayanagi H.(2011). Suppression of bone formation by osteoclastic expression of

semaphorin 4D. Nat Med, 17911):1473–1480.

Netter FH. (1987). The Ciba collection of medical illustrations. In: Woodburne

Russell T, Crelin Edmund S, Kaplan Frederick S., editors. Musculoskeletal system:

anatomy, physiology, and metabolic disorders. Part 1.Vol. 8. West Cauldwell, NJ:

Ciba-Geigy Pharmaceutical Products, p. 260.

Nijweidi PJ, Feyen JHM. (1986). Cells of bone: proliferation, differentiation, and

hormonal regulation. Physiol Rev, 66(4):855–886.

Ohashi M, Runge MS, Faraci FM, Heistad DD. (2006). MnSOD deficiency increases

endothelial dysfunction in ApoE-deficient mice. Arterioscler Thromb Vasc Biol,

26(10):2331–2336.

Okado-Matsumoto A, Fridovich I. (2001). Subcellular distribution of superoxide

dismutases (SOD) in rat liver: Cu, Zn-SOD in mitochondria. J Biol Chem,

276(42):38388–38393.

Old JL, Calvert M. (2004). Vertebral compression fractures in the elderly. Am Fam

Physician, 69(1):111–116.

Orwoll E. (1998). Osteoporosis in men. Endocrinol Metab Clin North Am,

2792):349–367.

Ou-Yang H, Paschalis EP, Mayo WE, Boskey AL, Mendelsohn R. (2001). Infrared

microscopic imaging of bone: Spatial distribution of CO3 (2–). J Bone Miner Res,

16(5):893–900.

Ozaki K, Kawata Y, Amano S, HanazawaS. (2000). Stimulatory effect of curcumin

on osteoclast apoptosis. Biochem Pharmacol, 59(12):1577–1581.


209

Pacifici R. (2010). The immune system and bone. Arch Biochem Biophys, 503(1):41-

53.

Paolicchi A, Dominici S, Pieri L, Maellaro E, Pompella A. (2002). Glutathione

catabolism as a signaling mechanism. Biochem Pharmacol, 64(5-6):1027–1035.

Patel RP, Cornwell T, Darley-Usmar VM. (1999). The biochemistry of nitric oxide

and peroxynitrite: implications for mitochondrial function. In Packer L, Cadenas

E. Understanding the process of aging: the roles of mitochondria, free radicals, and

antioxidants. New York, N.Y: Marcel Dekker, pp. 39–56.

Pearson KJ, Baur JA, Lewis KN, Peshkin L, Price NL, Labinskyy N, Swindell WR,

Kamara D, Minor RK, Perez E, Jamieson HA, Zhang Y, Dunn SR, Sharma K,

Pleshko N, Woollett LA, Csiszar A, Ikeno Y, Couteur DL, Elliott PJ, Becker KG,

Navas P, Ingram DK, Wolf NS, Ungvari Z, Sinclair DA, de Cabo R.(2008).

Resveratrol delays age-related deterioration and mimics transcriptional aspects of

dietary restriction without extending life span. Cell Metab, 8(2):157–168.

Pei L, Tontonoz P. (2004). Fat’s loss is bone’s gain. J Clin Invest, 113(6):805–806.

Perchellet JP, Perchellet EM, Abney NL, Zirnstein JA, Belman S. (1986). Effects of

garlic and onion oils on glutathione peroxides activity, the ratio of reduced and

oxidized glutathione and ornithine decarboxylase induction in isolated mouse

epidermal cells treated with tumor promoters. Cancer Biochem Biophys, 8(4):299–

312.

Quinn JM, Gillespie MT. (2005). Modulation of osteoclast formation. Biochem

Biophys Res Commun, 328(3):739–745.

Raabe T, Bukrinsky M, Currie RA. (1998). Relative contribution of transcription and

translation to the induction of tumor necrosis factor-α by lipopolysaccharides. J Biol

Chem, 273(2):974–980.

Rada B, Leto TL. (2008). Oxidative innate immune defenses by Nox/Duox family

NADPH oxidases. Contrib Microbiol, 15:164–187.


210

Radi R, Turrens JF, Chang LY, Bush KM, Crapo JD, Freeman BA. (1991). Detection

of catalase in rat heart mitochondria. J Biol Chem, 266(32):22028–22034.

Raisz L. (2005). Pathogenesis of osteoporosis: concepts, conflicts and prospects. J

Clin Invest, 115912):3318–3325.

Rayalam S, Della-Fera MA, Baile CA. (2011). Synergism between resveratrol and

other phytochemicals: implications for obesity and osteoporosis. Mol Nutr Food Res,

55(8):1177–1185.

Redlich K, Smolen JS. (2012). Inflammatory bone loss: pathogenesis and therapeutic

intervention. Nat Rev Drug Discov, 11(3):234-250.

Rhee SG, Chae HZ, Kim K. (2005). Peroxiredoxins: a historical overview and

speculative preview of novel mechanisms and emerging concepts in cell signaling.

Free Radic Biol Med, 38(12):1543–1552.

Riggs BL, Khosla S, Melton LJ 3rd. (1998). A unitary model for involutional

osteoporosis: estrogen deficiency causes both type I and type II osteoporosis in

postmenopausal women and contributes to bone loss in aging men. J Bone Miner Res,

1395):763-773.

Riggs BL, Khosla S, Melton LJ 3rd. (2002).Sex steroids and the construction and

conservation of the adult skeleton. Endocr Rev, 23(3):279–302.

Ringe J, Leinhase I, Stich S, Loch A, Neumann K, Haisch A, Haupl T, Manz R, Kaps

C, Sittinger M. (2008). Human mastoid periosteum-derived stem cells: promising

candidates for skeletal tissue engineering. J Tissue Eng Regen Med, 2(2-3):136–146.

Rizzoli R, Yasothan U, Kirkpatrick P. (2010). Fresh from the Pipeline:

denosumab. Nat Rev Drug Discov, 9(8):591–592.

Rouhi G. (2012). Biomechanics of osteoporosis: the importance of bone resorption

and remodeling processes, osteoporosis, PhD. Yannis Dionyssiotis (Ed.), ISBN: 978-

953-51-0026-3.


211

Roy B. (2013). Biomolecular basis of the role of diabetes mellitus in osteoporosis and

bone fractures. World J Diabetes, 4(4):101-113.

Rubin J, Rubin C, Jacobs CR. (2006). Molecular pathways mediating mechanical

signaling in bone. Gene, 367:1–16.

Rucci N. (2008). Molecular biology of bone remodelling. Clin Cases Miner Bone

Metab, 5(1):49–56.

Rukmini MS, D’Souza B, D’Souza V. (2004). Superoxide dismutase and catalyse

activities and their correlation with malondialdehyde in schizophrenic patients. Indian

J Clin Biochem, 19(2):114–118.

Ruoslahti E. (1991). Integrins. J Clin Invest, 87(1):1–5.

Saika M, Inoue D, Kido S, Matsumoto T. (2001). 17 beta-estradiol stimulates

expression of osteoprotegerin by a mouse stromal cell line, ST-2, via estrogen

receptor-alpha. Endocrinology, 142(6):2205-2212.

Salentijn L. (2007). Biology of mineralized tissues: cartilage and bone, Columbia

University College of Dental Medicine post-graduate dental lecture series.

Salkeld G, Cameron ID, Cumming RG, Easter S, Seymour J, Kurrle SE, Quine S.

(2000). Quality of life related to fear of falling and hip fracture in older women: a

time trade off study. BMJ, 320(7231):341–346.

Satoh K. 1978. Serum lipid peroxide in cerebrovascular disorders determined by a

new colorimetric method. Clin Chim Acta, 90(1):37-43.

Schmiedel BJ, Grosse-Hovest L, Salih HR. (2013). A “vicious cycle” of NK-cell

immune evasion in acute myeloid leukemia mediated by RANKL? Oncoimmunology,

12(5):e23850.

Schoppet M, Preissner KT, Hofbauer LC. (2002). RANK ligand and osteoprotegerin:

paracrine regulators of bone metabolism and vascular function. Arterioscler Thromb

Vasc Biol, 22(4):549–553.


212

Seeman E. (2003). Invited review: pathogenesis of osteoporosis. J Appl Physiol,

95(5):2142–2151.

Shakibaei M, Buhrmann C, Mobasheri A. (2011). Resveratrol-mediated SIRT-1

interactions with p300 modulate receptor activator of NF-Kappa b ligand (RANKL)

activation of NF-Kappa b signaling and inhibit osteoclastogenesis in bone-derived

cells. J Biol Chem, 286(13):11492-11505.

Shevde NK, Bendixen AC, Dienger KM, Pike JW. (2000). Estrogens suppress RANK

ligand-induced osteoclast differentiation via a stromal cell independent mechanism

involving c-Jun repression. Proc Natl Acad Sci U S A, 97(14):7829 –7834.

Simonet WS, Lacey DL, Dunstan CR, Kelley M, Chang MS, Luthy R, Nguyen HQ,

Wooden S, Bennett L, Boone T, Shimamoto G, DeRose M, Elliott R, Colombero A,

Tan HL, Trail G, Sullivan J, Davy E, Bucay N, Renshaw-Gegg L, Hughes TM, Hill

D, Pattison W, Campbell P, Sander S, Van G, Tarpley J, Derby P, Lee R, Boyle WJ.

(1997). Osteoprotegerin: a novel secreted protein involved in the regulation of bone

density. Cell, 89(2):309–319.

Singh R, Ahmed S, Islam N, Goldberg VM, Haqqi TM. (2002). Epigallocatechin-3-

Gallate inhibits interleukin-1-beta-induced expression of nitric oxide synthase and

production of nitric oxide in human chondrocytes: Suppression of Nuclear Factor

kappaB activation by degradation of the inhibitor of nuclear factor kappaB. Arthritis

Rheum, 46(8):2079-2086.

Siris ES. (1998). Paget’s disease of bone. J Bone Miner Res, 13(7):1061–1065.

Standring S. (2005). Gray's Anatomy. 39th ed, Elsevier.

Steinbeck MJ, Appel WH, Jr, Verhoeven AJ, Karnovsky MJ. (1994). NADPH-

oxidase expression and in situ production of superoxide by osteoclasts actively

resorbing bone. J Cell Biol, 126(3):765–772.

Suda N, Morita I, Kuroda T, Murota S. (1993). Participation of oxidative stress in the

process of osteoclast differentiation. Biochim Biophys Acta, 1157(3):318–323.


213

Suda T, Takahashi N, Martin TJ. (1992). Modulation of osteoclast differentiation

Endocr Rev, 13(1):66-80.

Suda T, Takahashi N, Udagawa N, Jimi E, Gillespie MT, Martin TJ. (1999).

Modulation of osteoclast differention and function by the new members of the tumor

necrosis factor receptor and ligand families. Endocr Rev, 20(3):345-357.

Szulc P, Garnero P, Marchand F, Duboeuf F, Delmas PD. (2005). Biochemical

markers of bone formation reflect endosteal bone loss in elderly men--MINOS

study. Bone, 36(1):13–21.

Tachibana H, Koga K, Fujimura Y, Yamada K.(2004). A receptor for green tea

polyphenol EGCG. Nat Struct Mol Biol, 11(4):380-381.

Takahashi N, Akatsu T, Udagawa N,Sasaki T, Yamaguchi A, Moseley JM, Martin

TJ, Suda T. (1988). Osteoblastic cells are involved in osteoclast formation.

Endocrinology, 123(5):2600-2602.

Takita H, Kikuchi M, Sato Y, Kuboki Y. (2002). Inhibition of BMP-induced ectopic

bone formation by an antiangiogenic agent (epigallocatechin 3-gallate). Connect

Tissue Res, 43(2-3):520-523.

Tanaka S, Miyazaki T, Fukuda A, Akiyama T, Kadono Y, Wakeyama H, Kono S,

Hoshikawa S, Nakamura M, Ohshima Y, Hikita A, Nakamura I, Nakamura K. (2006).

Molecular mechanism of the life and death of the osteoclast. Ann N Y Acad Sci,

1068:180–186.

Tate M, Adamson TA Jr, Bauer TW. (2004). Cells in focus. The osteocyte. Int J

Biochem Cell Biol, 36(1):1–8.

Teitelbaum SL. (2007). Osteoclasts: what do they do and how do they do it? Am J

Pathol, 170(2):427–435.

Theill LE, Boyle WJ, Penninger JM. (2002). RANK-L and RANK: T cells, bone loss,

and mammalian evolution. Annu Rev Immunol, 20:795–823.


214

Tissenbaum HA, Guarente L. (2001). Increased dosage of a sir-2 gene extends

lifespan in Caenorhabditis elegans. Nature, 410(6825):227–230.

Toossi Z, Hirsch CS, Hamilton BD, Knuth CK, Friedlander MA, Rich EA. (1996).

Decreased production of TGF-beta 1 by human alveolar macrophages compared with

blood monocytes. J Immunol, 156(9):3461-3468.

Tseng PC, Hou SM, Chen RJ, Peng HW, Hsieh CF, Kuo ML, Yen ML. (2011).

Resveratrol promotes osteogenesis of human mesenchymal stem cells by up

regulating RUNX2 gene expression via the SIRT1/FOXO3A axis. J Bone Miner Res,

26(10):2552–2563.

U.S. Department of Health and Human Services, Washington, DC. (2004).

Udagawa N, Takahashi N, Akatsu T, Tanaka H, Sasaki T, Nishihara T, Martin TJ,

Suda T. (1990). Origin of osteoclasts: Mature monocytes and macrophages are

capable of differentiating into osteoclasts under a suitable microenvironment prepared

by bone marrow-derived stromal cells. Proc. Natl. Acad. Sci. USA, 87(18):7260-

7264.

Vaananen H, Zhao H, Mulari M, Halleen J. (2000). The cell biology of osteoclast

function. J Cell Sci, 113(Pt 3):377–381.

Vali H, Rao LG, El-Sohemy A. (2007). Epigallocatechin-3-gallate increases the

formation of mineralized bone nodules by human osteoblast-like cells. J Nutr

Biochem, 18(5):341-347.

Vita JA. (2003). Tea consumption and cardiovascular disease: effects on endothelial

function. J Nutr, 133(10):3293S–3297S.

Wada T, Nakashima T, Hiroshi N, Penninger JM. (2006). RANKL-RANK signaling

in osteoclastogenesis and bone disease. Trends Mol Med, 12(1):17–25.

Wang B, Lai X, Price C, Thompson WR, Li W, Quabili TR, Tseng WJ, Liu

XS, Zhang H, Pan J, Kirn-Safran CB, Farach-Carson MC, Wang L. (2014). Perlecan-


215

containing pericellular matrix regulates solute transport and mechanosensing within

the osteocyte lacunar-canalicular system. J Bone Miner Res, 29(4):878-891.

Wang HD, Shi YM, Li L, Guo JD, Zhang YP, Hou SX. (2013). Treatment with

resveratrol attenuates sublesional bone loss in spinal-cord-injured rats. Br J

Pharmacol, 170(4):796–806.

Wang R, Zhou W, Jiang X. (2008). Reaction kinetics of degradation and

epimerization of epigallocatechingallate (EGCG) in aqueous system over a wide

temperature range. J Agric Food Chem, 56(8):2694–2701.

Wariaghli G, Allali F, Maghraoui AE, Hajjaj- Hassouni N. (2010). Osteoporosis in

patients with primary biliary cirrhosis. Eur J Gastroenterol Hepatol, 22(12):1397-

1401.

Wauquier F, Leotoing L, Coxam V, Guicheux J, Wittrant Y. (2009). Oxidative stress

in bone remodelling and disease. Trends Mol Med, 15(10):468-477.

Weber JM, Forsythe SR, Christianson CA, Frisch BJ, Gigliotti BJ, Jordan CT, Milner

LA, Guzman ML, Calvi LM. (2006). Parathyroid hormone stimulates expression of

the Notch ligand Jagged1 in osteoblastic cells. Bone, 39(3):485–493.

Wein MN, Jones DC, Glimcher LH. (2005). Turning down the system: Counter-

regulatory mechanisms in bone and adaptive immunity. Immunol Rev, 208:66–79.

Wensel TM, Iranikhah MM, Wilborn TW. (2011). Effects of denosumab on bone

mineral density and bone turnover in postmenopausal women. Pharmacotherapy,

31(5):510–523.

West AP, Shadel GS, Ghosh S. (2011).Mitochondria in innate immune responses. Nat

Rev Immunol, 11(6):389–402.

Weydert CJ, Cullen JJ. (2010). Measurement of superoxide dismutase, catalase and

glutathione peroxidase in cultured cells and tissue. Nature Protocols, 5(1):51 – 66.

Wheeler DS, Catravas JD, Odoms K, Denenberg A, Malhotra V, Wong HR. (2004).

Epigallocatechin-3-gallate, a green tea-derived polyphenol, inhibits IL-1 beta-


216

dependent proinflammatory signal transduction in cultured respiratory epithelial cells.

J Nutr, 134(5):1039–1044.

WHO (1994). Assessment of fracture risk and its application to screening for

postmenopausal osteoporosis. Report of a WHO Study Group. World Health Organ

Tech Rep Ser, 843:1–129.

WHO Scientific Group on the Prevention and Management of Osteoporosis (2000:

Geneva, Switzerland). (2003). Prevention and management of osteoporosis: report of

a WHO scientific group.

Winterbourn CC. (2008). Reconciling the chemistry and biology of reactive oxygen

species. Nat Chem Biol, 4(5):278–286.

Wittrant Y, Gorin Y, Woodruff K, Horn D, Abboud HE, Mohan S, Abboud-Werner

SL. (2008). High d(+)glucose concentration inhibits RANKL-induced

osteoclastogenesis. Bone, 42(6):1122–1130.

Wittrant Y, Theoleyre S, Chipoy C, Padrines M, Blanchard F, Heymann D, Redini F.

(2004). RANKL/RANK/OPG: new therapeutic targets in bone tumours and associated

osteolysis. Biochim Biophys Acta, 1704(2):49– 57.

Wolff J. (1892). The law of bone remodeling. Springer-Verlag, Berlin, New York.

Wong BR, Josien R, Choi Y (1999). TRANCE is a TNF family member that

regulates dendritic cell and osteoclast function. J Leukoc Biol, 65(6):715–724.

Wong BR, Rho J, Arron J, Robinson E, Orlinick J, Chao M, Kalachikov S, Cayani E,

Bartlett FS, Frankel WN, Lee SY, Choi Y. (1997). TRANCE is a novel ligand of the

tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T

cells. J Biol Chem, 272(40):25190–25194.

Wongdee K, Charoenphandhu N. (2011). Osteoporosis in diabetes mellitus: possible

cellular and molecular mechanisms. World J Diabetes, 2(3):41-48.

Yamaguchi M, Moore TW, Sun A, Snyder JP, Shoji M. (2012). Novel

curcumin analogue UBS109 potently stimulates osteoblastogenesis and suppresses


217

osteoclastogenesis: involvement in Smad activation and NF-κB inhibition. Integr Biol

(Camb), 4(8):905-913.

Yang EJ, Lee J, Lee SY, Kim EK, Moon YM, Jung YO, Park SH, Cho ML. (2014).

EGCG attenuates autoimmune arthritis by inhibition of STAT3 and HIF-1a with

Th17/Treg control. PLoS One 9(2):e86062.

Yang N, Wan G, Hu C, Shi Y, Liao L, Shi S, Cai Y, Cheng S, Wang S, Liu Y, Tang

L, Ding Y, Jin Y. (2013). Tumor necrosis factor α suppresses the mesenchymal stem

cell osteogenesis promoter miR-21 in estrogen deficiency induced osteoporosis. J

Bone Miner Res, 28(3):559-573.

Yasuda H, Shima N, Nakagawa N, Yamaguchi K, Kinosaki M, Mochizuki

S, Tomoyasu A, Yano K, Goto M, Murakami A, Tsuda E, Morinaga T, Higashio K,

Udagawa N, Takahashi N, Suda T. (1998). Osteoclast differentiation factor is a ligand

for osteoprotegerin/ osteoclastogenesis-inhibitory factor and is identical to

TRANCE/RANKL. Proc Natl Acad Sci, USA, 95(7):3597-3602.

Yasuda H. (2013). RANKL, a necessary chance for clinical application to

osteoporosis and cancer-related bone diseases. World J Orthop, 4(4):207-217.

Yoon WJ, Islam R, Cho YD, Woo KM, Baek JH, Uchida T, Komori T, van Wijnen

A, Stein J L, Lian JB, Stein GS, Choi JY, Bae SC, Ryoo HM. (2013). Pin1-mediated

Runx2 modification is critical for skeletal development. J Cell Physiol, 228(12):2377-

2385.

Yoshida H, Hayashi S, Kunisada T,Ogawa M, Nishikawa S, Okamura H, Sudo

T, Shultz LD, Nishikawa S. (1990). The murine mutation osteopetrosis is in the

coding region of the macrophage colony stimulating factor gene. Nature,

345(6274):442-444.

You J, Yellowley CE, Donahue HJ, Zhang Y, Chen Q, Jacobs CR. (2000). Substrate

deformation levels associated with routine physical activity are less stimulatory to

bone cells relative to loading-induced oscillatory fluid flow. J Biomech

Eng, 122(4):387–393.


218

Yu TH, Wu C-M. (1989). Stability of allicin in garlic juice. J Food Sci, 54, 977–981.

Yu W, Fu YC, Wang W. (2012). Cellular and molecular effects of resveratrol in

health and disease.J Cell Biochem, 113(3):752-759.

Yun JH, Kim CS, Cho KS, Chai JK, Kim CK, Choi SH. (2007). (-)-Epigallocatechin

gallate induces apoptosis, via caspase activation, in osteoclasts differentiated from

RAW 264.7 cells. J Periodontal Res, 42(3):212–218.

Zaidi M, Blair HC, Moonga BS, Abe E, Huang CL. (2003). Osteoclastogenesis, bone

resorption, and osteoclast-based therapeutics. J Bone Miner Res, 18(4):599–609.

Zhao R, Kamon M, Sakamoto K. (2014). (–)-Epigallocatechin gallate interferes

RANKL/RANK signal pathway and induces apoptosis during osteoclastogenesis in

RAW264 cell. Food Nutr Sci, 5(2):107-116.

Zivna H, Micuda S, Brcakova-Dolezelova E, Zivny P. (2013). The effect of

resveratrol on bone status in rats with bile duct obstruction. O J Endocrin Metab Dis,

3(1):46-51.

BIBLIOGRAPHY -...

Documents

Transcript of BIBLIOGRAPHY -...